Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer

by Quisette P. Janssen, Eileen M. O'Reilly, Eileen M. O'Reilly, Casper H. J. van Eijck, Bas Groot Koerkamp
Published 2020-01-01

Duration of therapy for locally advanced pancreatic cancer: Does it matter?

by Richard Tuli, John David, Stephanie Lobaugh, Zhigang Zhang, Eileen M. O'Reilly
Published 2020-07-01

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior

by Ibrahim H. Sahin, Harold Elias, Joanne F. Chou, Marinela Capanu, Eileen M. O’Reilly
Published 2018-07-01

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes

by Eileen M. O'Reilly, Paul Cockrum, Andy Surinach, Zheng Wu, Allison Dillon, Kenneth H. Yu
Published 2020-11-01

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients

by Mashaal Dhir, Gautam K. Malhotra, Davendra P.S. Sohal, Nicholas A. Hein, Lynette M. Smith, Eileen M. O’Reilly, Nathan Bahary, Chandrakanth Are
Published 2017-10-01

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma

by Gokce Askan, Ibrahim Halil. Sahin, Joanne F. Chou, Aslihan Yavas, Marinela Capanu, Christine A. Iacobuzio-Donahue, Olca Basturk, Eileen M. O’Reilly
Published 2021-04-01

Acquired resistance to immunotherapy in MMR-D pancreatic cancer

by Zishuo Ian Hu, Matthew D. Hellmann, Jedd D. Wolchok, Monika Vyas, Jinru Shia, Zsofia K. Stadler, Luis A. Diaz, Eileen M. O’Reilly
Published 2018-11-01

Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer

by Agnieszka K. Witkiewicz, Uthra Balaji, Cody Eslinger, Elizabeth McMillan, William Conway, Bruce Posner, Gordon B. Mills, Eileen M. O’Reilly, Erik S. Knudsen
Published 2016-08-01

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

by Kenneth H. Yu, Mark Ricigliano, Brian McCarthy, Joanne F. Chou, Marinela Capanu, Brandon Cooper, Andrew Bartlett, Christina Covington, Maeve A. Lowery, Eileen M. O’Reilly
Published 2018-11-01

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

by Jayasree Chakraborty, Liana Langdon-Embry, Kristen M Cunanan, Joanna G Escalon, Peter J Allen, Maeve A Lowery, Eileen M O'Reilly, Mithat Gönen, Richard G Do, Amber L Simpson
Published 2017-01-01

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study

by Saroj Vadhan‐Raj, Mairéad G. McNamara, Marino Venerito, Hanno Riess, Eileen M. O'Reilly, Michael J. Overman, Xiao Zhou, Ujjwala Vijapurkar, Simrati Kaul, Peter Wildgoose, Alok A. Khorana
Published 2020-09-01

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

by Danielle C. Glassman, Randze L. Palmaira, Christina M. Covington, Avni M. Desai, Geoffrey Y. Ku, Jia Li, James J. Harding, Anna M. Varghese, Eileen M. O’Reilly, Kenneth H. Yu
Published 2018-06-01

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib

by Imane El Dika, Marinela Capanu, Joanne F. Chou, James J. Harding, Michele Ly, Anna D. Hrabovsky, Richard K.G. Do, Jinru Shia, Brittanie Millang, Jennifer Ma, Eileen M. O’Reilly, Ghassan K. Abou‐Alfa
Published 2020-10-01

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer

by Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, Tamara Matysiak-Budnik, Jean-Luc Van Laethem, Teresa Macarulla, Estelle Cauchin, Alexander Kleger, Alica K. Beutel, Johann Gout, Albrecht Stenzinger, Eric Van Cutsem, Joaquim Bellmunt, Pascal Hammel, Eileen M. O’Reilly, Thomas Seufferlein
Published 2021-08-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

by Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen
Published 2012-01-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers.

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01

A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

by Zishuo Ian Hu, Johanna C. Bendell, Andrea Bullock, Noelle K. LoConte, Hassan Hatoum, Paul Ritch, Hugo Hool, Joseph W. Leach, James Sanchez, Davendra P. S. Sohal, John Strickler, Ravindranath Patel, Andrea Wang‐Gillam, Irfan Firdaus, Kenneth H. Yu, Ann M. Kapoun, Eric Holmgren, Lei Zhou, Jakob Dupont, Vincent Picozzi, Vaibhav Sahai, Eileen M. O'Reilly
Published 2019-09-01